Cadian Capital Management, LP Blueprint Medicines Corp Transaction History

Cadian Capital Management, LP

$1.95 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $28 Million - $43.6 Million	-561,198 Reduced 27.77%	1,459,431 $96.2 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $4.49 Million - $6.96 Million	99,282 Added 5.17%	2,020,629 $102 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $79.6 Million - $162 Million	1,470,690 Added 326.34%	1,921,347 $123 Million
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $56.7 Million - $69.8 Million	-601,546 Reduced 57.17%	450,657 $48.3 Million
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $21.8 Million - $29.5 Million	-269,110 Reduced 20.37%	1,052,203 $108 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $33.7 Million - $41.2 Million	407,611 Added 44.61%	1,321,313 $116 Million
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $13.2 Million - $15.8 Million	-145,748 Reduced 13.76%	913,702 $88.8 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $150 Million - $203 Million	-1,627,406 Reduced 60.57%	1,059,450 $119 Million
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $98.9 Million - $138 Million	1,488,867 Added 124.28%	2,686,856 $249 Million
Q2 2020 Aug 13, 2020	SELL	$57.09 - $79.27 $1.6 Million - $2.23 Million	-28,107 Reduced 2.29%	1,197,989 $93.4 Million
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $35.7 Million - $61 Million	-741,942 Reduced 37.7%	1,226,096 $71.7 Million
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $36.7 Million - $45.4 Million	549,334 Added 38.72%	1,968,038 $158 Million
Q3 2019 Nov 13, 2019	BUY	$72.9 - $101.41 $65.3 Million - $90.8 Million	895,443 Added 171.13%	1,418,704 $104 Million
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $23.8 Million - $31.6 Million	323,261 Added 161.63%	523,261 $49.4 Million
Q1 2019 May 14, 2019	BUY	$48.7 - $86.6 $9.74 Million - $17.3 Million	200,000 New	200,000 $16 Million
Q4 2017 Feb 13, 2018	SELL	$62.91 - $88.32 $19.8 Million - $27.7 Million	-313,965 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$42.37 - $69.67 $13.3 Million - $21.9 Million	313,965	313,965 $21.9 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cadian Capital Management, LP with notifications on news.

Account